The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH

Biomaterials

Volumn 32, Issue 22, 2011, Pages 5262-5268

  Kim, Hyo Young ^a   Kim, Seunghoo ^b   Youn, Hyewon ^b   Chung, June Key ^b   Shin, Dong Hae ^a   Lee, Kyunglim ^a  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Apoptosis; Cancer; Molecular imaging; Protein transduction domain; TCTP

Indexed keywords

APOPTOSIS; CANCER; MOLECULAR IMAGING; PROTEIN TRANSDUCTION DOMAIN; TCTP;

BACTERIOPHAGES; CELL DEATH; CELL MEMBRANES; DISEASES; PEPTIDES;

TUMORS;

HYBRID PROTEIN; LYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSYLLYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSINE; METHIONYLISOLEUCYLISOLEUCYLTYROSYLARGINYLASPARTYLLEUCYLISOLEUCYLSERYLHISTIDINE; PEPTIDE DERIVATIVE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONJUGATION; DRUG TUMOR LEVEL; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; LUNG CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL LINE; CELL-PENETRATING PEPTIDES; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 79956076191     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.074     Document Type: Article

References (31)

1. Snyder E.L., Dowdy S.F. Cell penetrating peptides in drug delivery. Pharm Res 2004, 21(3):389-393.
2. Denicourt C., Dowdy S.F. Protein transduction technology offers novel therapeutic approach for brain ischemia. Trends Pharmacol Sci 2003, 24(5):216-218.
3. Fischer R., Fotin-Mleczek M., Hufnagel H., Brock R. Break on through to the other side - biophysics and cell biology shed light on cell-penetrating peptides. Chembiochem 2005, 6(12):2126-2142.
4. Kim M., Kim M., Kim H.Y., Kim S., Jung J., Maeng J., et al. A protein transduction domain located at the NH2-terminus of human translationally controlled tumor protein for delivery of active molecules to cells. Biomaterials 2011, 32(1):222-230.
5. Foillard S., Jin Z.H., Garanger E., Boturyn D., Favrot M.C., Coll J.L., et al. Synthesis and biological characterisation of targeted pro-apoptotic peptide. Chembiochem 2008, 9(14):2326-2332.
6. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D., et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 1999, 5(9):1032-1038.
7. Javadpour M.M., Juban M.M., Lo W.C., Bishop S.M., Alberty J.B., Cowell S.M., et al. De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem 1996, 39(16):3107-3113.
8. Kwon M.K., Nam J.O., Park R.W., Lee B.H., Park J.Y., Byun Y.R., et al. Antitumor effect of a transducible fusogenic peptide releasing multiple proapoptotic peptides by caspase-3. Mol Cancer Ther 2008, 7(6):1514-1522.
9. Law B., Quinti L., Choi Y., Weissleder R., Tung C.H. A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. Mol Cancer Ther 2006, 5(8):1944-1949.
10. Mai J.C., Mi Z., Kim S.H., Ng B., Robbins P.D. A proapoptotic peptide for the treatment of solid tumors. Cancer Res 2001, 61(21):7709-7712.
11. Mi Z., Mai J., Lu X., Robbins P.D. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol Ther 2000, 2(4):339-347.
12. Thornberry N.A., Rosen A., Nicholson D.W. Control of apoptosis by proteases. Adv Pharmacol 1997, 41:155-177.
13. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281(5381):1312-1316.
14. Ellerby H.M., Bredesen D.E., Fujimura S., John V. Hunter-killer peptide (HKP) for targeted therapy. J Med Chem 2008, 51(9):5887-5892.
15. Marks A.J., Cooper M.S., Anderson R.J., Orchard K.H., Hale G., North J.M., et al. Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide. Cancer Res 2005, 65(6):2373-2377.
16. Ko Y.T., Falcao C., Torchilin V.P. Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy. Mol Pharmacol 2009, 6(3):971-977.
17. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., et al. Cell-penetrating peptides - a reevaluation of the mechanism of cellular uptake. J Biol Chem 2003, 278(1):585-590.
18. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 2000, 97(24):13003-13008.
19. Yoo S.A., Bae D.G., Ryoo J.W., Kim H.R., Park G.S., Cho C.S., et al. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes. J Immunol 2005, 174(9):5846-5855.
20. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M., Newham P., et al. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol 2005, 145(8):1093-1102.
21. Console S., Marty C., Garcia-Echeverria C., Schwendener R., Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 2003, 278(37):35109-35114.
22. Tyagi M., Rusnati M., Presta M., Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001, 276(5):3254-3261.
23. Jourdain A., Martinou J.C. Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int J Biochem Cell Biol 2009, 41(10):1884-1889.
24. Brooks C., Dong Z. Regulation of mitochondrial morphological dynamics during apoptosis by Bcl-2 family proteins: a key in Bak?. Cell Cycle 2007, 6(24):3043-3047.
25. Caroppi P., Sinibaldi F., Fiorucci L., Santucci R. Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein. Curr Med Chem 2009, 16(31):4058-4065.
26. Bratton S.B., Walker G., Srinivasula S.M., Sun X.M., Butterworth M., Alnemri E.S., et al. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J 2001, 20(5):998-1009.
27. Gump J.M., Dowdy S.F. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 2007, 13(10):443-448.
28. Hakansson S., Jacobs A., Caffrey M. Heparin binding by the HIV-1 tat protein transduction domain. Protein Sci 2001, 10(10):2138-2139.
29. Rusnati M., Coltrini D., Oreste P., Zoppetti G., Albini A., Noonan D., et al. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J Biol Chem 1997, 272(17):11313-11320.
30. Moffitt K.L., Martin S.L., Walker B. The emerging role of serine proteases in apoptosis. Biochem Soc Trans 2007, 35(Pt 3):559-560.
31. Salvesen G.S., Duckett C.S. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002, 3(6):401-410.